ELV
Elevance Health Inc
414.30$
+0.4%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.1% | -7.0% | 4.6% | 1.0% | 5.9% | 1.6% | 2.1% | 4.1% | 2.2% | 0.2% | 8.6% | 3.8% | 3.7% | |
| 1.0% | 1.0% | 0.8% | 0.8% | 0.7% | 0.9% | 0.8% | 0.8% | 0.8% | 0.8% | 0.7% | 0.7% | 0.8% | |
| 0.2% | 0.2% | 0.1% | 0.2% | 0.1% | -0.1% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | |
| 1.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.5% | -10.2% | -2.3% | -4.5% | 2.8% | 0.0% | -3.7% | -0.4% | -1.5% | -1.1% | 2.1% | 0.1% | -0.1% | |
| 0.7% | 0.8% | 0.7% | 0.7% | 0.7% | 0.7% | 0.4% | 0.5% | 0.7% | 0.6% | 0.5% | 0.6% | 0.6% | |
| -10.6% | -2.4% | -5.4% | -1.9% | -0.9% | -3.6% | 0.2% | -1.4% | -2.4% | 0.9% | -3.3% | 0.3% | -1.1% | |
| 0.8% | 0.8% | 0.9% | 0.9% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.7% | 0.7% | 0.7% | |
| -1.1% | -2.2% | -1.3% | -1.1% | -0.1% | -4.0% | -1.8% | -0.8% | -1.7% | -0.9% | -2.2% | -0.5% | -1.3% | |
| -0.5% | – | – | – | -0.8% | 8.4% | -1.7% | 0.4% | 2.7% | 3.2% | -2.6% | -1.5% | 0.4% | |
| -2.3% | -0.9% | 0.1% | 1.5% | -2.0% | 3.1% | -3.9% | -0.6% | 0.5% | 0.5% | -5.0% | -3.0% | -1.8% | |
| 2.2% | -10.3% | -0.7% | 0.6% | 3.0% | 0.9% | -1.6% | 2.1% | 0.3% | 1.6% | 0.3% | 1.1% | 0.8% | |
| 5.4% | -7.7% | 4.0% | 0.3% | 5.2% | 0.8% | 1.7% | 3.6% | 1.5% | -0.4% | 8.2% | 3.2% | 3.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.